全文获取类型
收费全文 | 713篇 |
免费 | 46篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 22篇 |
妇产科学 | 3篇 |
基础医学 | 71篇 |
口腔科学 | 13篇 |
临床医学 | 103篇 |
内科学 | 167篇 |
皮肤病学 | 14篇 |
神经病学 | 57篇 |
特种医学 | 152篇 |
外科学 | 20篇 |
综合类 | 16篇 |
预防医学 | 36篇 |
眼科学 | 1篇 |
药学 | 93篇 |
肿瘤学 | 35篇 |
出版年
2022年 | 4篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 9篇 |
2015年 | 15篇 |
2014年 | 8篇 |
2013年 | 15篇 |
2012年 | 19篇 |
2011年 | 15篇 |
2010年 | 15篇 |
2009年 | 14篇 |
2008年 | 22篇 |
2007年 | 49篇 |
2006年 | 16篇 |
2005年 | 25篇 |
2004年 | 12篇 |
2003年 | 18篇 |
2002年 | 19篇 |
2001年 | 15篇 |
2000年 | 23篇 |
1999年 | 22篇 |
1998年 | 32篇 |
1997年 | 33篇 |
1996年 | 30篇 |
1995年 | 30篇 |
1994年 | 22篇 |
1993年 | 27篇 |
1992年 | 24篇 |
1991年 | 16篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 26篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 23篇 |
1984年 | 13篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 14篇 |
1976年 | 9篇 |
1975年 | 4篇 |
1962年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有805条查询结果,搜索用时 15 毫秒
731.
心脏移植和心肺移植现状与相关问题的探讨 总被引:5,自引:0,他引:5
目前全世界300多个心脏中心进行心脏移植,总例数已超过7万,每年3000多例,30 d手术死亡率5%~10%.2005年国际心肺移植注册协会报告70 201例心脏移植患者,1 a存活率79%,以后每年以4%死亡率递减,最长存活病例已超过30 a.根据国际多中心研究结果显示死亡原因22%为急性心衰,22%为感染,15%为排斥反应,随着移植时间延长冠状动脉病变和恶性肿瘤等也是主要死亡原因.目前我国心脏移植大约300例.心肺移植术开展较心脏移植术晚,手术与术后处理都较心脏移植难度大,目前全世界共开展心肺移植3000例左右,1 a生存率72%.西京医院2000-01/2005-07共开展同种异体原位心脏移植29例,1 a存活率79%,其中2003年后11例术后无手术并发症、排斥反应及死亡.本文结合文献分析和移植经验探讨几个有关问题. 相似文献
732.
Mélanie Fortier Christian-Alexandre Castellano Etienne Croteau Francis Langlois Christian Bocti Valérie St-Pierre Camille Vandenberghe Michaël Bernier Maggie Roy Maxime Descoteaux Kevin Whittingstall Martin Lepage Éric E. Turcotte Tamas Fulop Stephen C. Cunnane 《Alzheimer's & dementia》2019,15(5):625-634
IntroductionUnlike for glucose, uptake of the brain's main alternative fuel, ketones, remains normal in mild cognitive impairment (MCI). Ketogenic medium chain triglycerides (kMCTs) could improve cognition in MCI by providing the brain with more fuel.MethodsFifty-two subjects with MCI were blindly randomized to 30 g/day of kMCT or matching placebo. Brain ketone and glucose metabolism (quantified by positron emission tomography; primary outcome) and cognitive performance (secondary outcome) were assessed at baseline and 6 months later.ResultsBrain ketone metabolism increased by 230% for subjects on the kMCT (P < .001) whereas brain glucose uptake remained unchanged. Measures of episodic memory, language, executive function, and processing speed improved on the kMCT versus baseline. Increased brain ketone uptake was positively related to several cognitive measures. Seventy-five percent of participants completed the intervention.DiscussionA dose of 30 g/day of kMCT taken for 6 months bypasses a significant part of the brain glucose deficit and improves several cognitive outcomes in MCI. 相似文献
733.
734.
735.
736.
Armand Frappier Marcel Cantin Lise Davignon Jacques St-Pierre Pierre Robillard Thrse Gauthier 《Canadian Medical Association journal》1971,105(7):707-710
The BCG vaccination program officially set up in 1949 in the Province of Quebec has been retrospectively evaluated for the period from 1956 to 1961. Two series of age groups were studied, 0-14 and 15-29, each comprising populations of several hundred thousand. At the beginning and the end of the period, the rates of primary vaccination were, in percentages of viable births, from 40 to 47.8 and, in cumulative percentages, for the 0 to 14 year age group, from 39.98 to 53.41, and for the 0 to 29 year age group, from 29.22 to 45.98.
During this period, the ratios between the yearly rates of incidence of new cases of pulmonary tuberculosis per 100,000 in vaccinated and non-vaccinated individuals ranged from 1-2.5 to 1-3.5 within the age group 0-14 years and from 1-4.5 to 1-7 within the age group 15-29 years. When only the incidence of the more severe forms of tuberculosis is considered, the ratios ranged from 1-3.7 to 1-6.0 for the younger group and from 1-5.3 to 1-7.6 for the older one.
Mortality from pulmonary tuberculosis was practically non-existent in the vaccinated groups and decreased from 2.5 to 1.3 per 100,000 population in the non-vaccinated groups.
相似文献737.
M T-Benchekroun A Fournier S St-Pierre A Cadieux 《European journal of pharmacology》1992,216(3):421-428
The effect of neuropeptide Y (NPY) was tested on isolated guinea pig trachea. At 30 nM, NPY induced a weak but significant contractile response which was on average less than 6% of responses elicited by standard spasmogens. This myotropic action of NPY was blocked by indomethacin. In addition to its contractile activity, NPY greatly reduced the maximal response to vasoactive intestinal peptide (VIP), noradrenaline (NA), substance P (SP) and 5-hydroxytryptamine (5-HT), without affecting their pD2 values. However, NPY did not influence the response induced by histamine and carbamylcholine. Pretreatment of tracheal spirals with indomethacin (10(-6) M) abolished the NPY-evoked inhibition of VIP, SP and 5-HT responses but failed to reduce the action of NPY on NA-elicited relaxation. This latter effect was however blocked in the presence of tetrodotoxin. In conclusion, NPY inhibits responses elicited by various agonists in the guinea pig trachea. This effect seems to be mediated at both pre- and postjunctional levels. The postjunctionally mediated inhibitory action of NPY appears to be expressed especially with agents that generate prostaglandins concomitantly with inducing their response. In contrast, the NPY-evoked inhibition of NA-evoked relaxation seems to be mediated via a prejunctional mechanism. 相似文献
738.
739.
740.